Amarin Corp Plcuk (AMRN) Property, Plant & Equipment (Net) (2010 - 2025)

Amarin Corp Plcuk (AMRN) Property, Plant & Equipment (Net) (2010 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 26.54 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 23.27 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 5.69 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 13.12 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 25.43 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 8.22 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 5.64 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 19.40 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 12,000.00
Dec 31, 2025 12,000.00
Sep 30, 2025 13,000.00
Sep 30, 2025 13,000.00
Jun 30, 2025 14,000.00
Jun 30, 2025 14,000.00
Mar 31, 2025 15,000.00
Mar 31, 2025 15,000.00
Dec 31, 2024 16,000.00
Dec 31, 2024 16,000.00
Sep 30, 2024 24,000.00
Sep 30, 2024 24,000.00
Jun 30, 2024 49,000.00
Jun 30, 2024 49,000.00
Mar 31, 2024 81,000.00
Mar 31, 2024 81,000.00
Dec 31, 2023 114,000.00
Dec 31, 2023 114,000.00
Sep 30, 2023 147,000.00
Sep 30, 2023 147,000.00